PaxMedica (PXMD) Competitors

PaxMedica (NASDAQ:PXMD) and Calithera Biosciences (NASDAQ:CALA) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, community ranking, valuation and institutional ownership.

Which has higher valuation and earnings, PXMD or CALA?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PaxMedica	N/A	N/A	-$18.29M	N/A	N/A
Calithera Biosciences	N/A	N/A	-$39.65M	N/A	N/A

Which has more volatility & risk, PXMD or CALA?

PaxMedica has a beta of -0.46, suggesting that its stock price is 146% less volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -0.48, suggesting that its stock price is 148% less volatile than the S&P 500.

Is PXMD or CALA more profitable?

Calithera Biosciences' return on equity of 0.00% beat PaxMedica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PaxMedica	N/A	-3,167.89%	-560.35%
Calithera Biosciences	N/A	N/A	N/A

Does the MarketBeat Community favor PXMD or CALA?

Calithera Biosciences received 340 more outperform votes than PaxMedica when rated by MarketBeat users. However, 100.00% of users gave PaxMedica an outperform vote while only 56.09% of users gave Calithera Biosciences an outperform vote.

Company	Underperform	Outperform
PaxMedica	Outperform Votes 1 100.00%	Underperform Votes No Votes
Calithera Biosciences	Outperform Votes 341 56.09%	Underperform Votes 267 43.91%

Does the media refer more to PXMD or CALA?

In the previous week, Calithera Biosciences had 1 more articles in the media than PaxMedica. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for PaxMedica. PaxMedica's average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score.

Company	Overall Sentiment
PaxMedica	Neutral
Calithera Biosciences	Neutral

Do insiders & institutionals believe in PXMD or CALA?

4.9% of PaxMedica shares are owned by institutional investors. 1.0% of PaxMedica shares are owned by company insiders. Comparatively, 6.6% of Calithera Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Calithera Biosciences beats PaxMedica on 5 of the 9 factors compared between the two stocks.